Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 1, 2023 7:16 AM 2 min read

$3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

by Lisa Levin Benzinga Editor
Follow

The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

authID

  • The Trade: authID Inc. (NASDAQ:AUID) 10% owner Stephen Jeffrey Garchik acquired a total 6,465,612 shares an average price of $0.47. To acquire these shares, it cost around $3.02 million.
  • What’s Happening: AuthID posted a narrower first-quarter loss.
  • What authID Does: AuthID Inc is a provider of an Identity as a Service (IDaaS) platform that delivers a suite of secure, mobile, biometric identity solutions.

Altus Power

  • The Trade: Altus Power, Inc. (NYSE:AMPS) Director, Co-Founder, Co-CEO, Co-President Gregg Felton acquired a total of 22,500 shares at an average price of $4.49. The insider spent around $101.13 thousand to buy those shares.
  • What’s Happening: Altus Power reported better-than-expected first-quarter financial results.
  • What Altus Power Does: Altus Power Inc is a renewable energy generation company focused on the commercial and industrial, public sector, and community solar customers.

SpringBig Holdings

  • The Trade: SpringBig Holdings, Inc. (NASDAQ:SBIG) Director Jonathan Trauben acquired a total of 97,318 shares at an average price of $0.30. To acquire these shares, it cost around $28.89 thousand.
  • What’s Happening: SpringBig Holdings priced a $4 million offering.
  • What SpringBig Holdings Does: SpringBig Holdings Inc is a software platform providing customer loyalty and marketing automation solutions to cannabis retailers and brands in the U.S. and Canada.

Check This Out: Top 5 Tech And Telecom Stocks That Are Flying - And May Collapse

Don’t forget to check out our premarket coverage here

HCW Biologics

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Long IdeasNewsPenny StocksSmall CapInsider TradesPre-Market OutlookMarketsTrading IdeasPenny Stocks Insider Buying
AUID Logo
AUIDAuthID Inc
$1.787.23%
Overview
HCWB Logo
HCWBHCW Biologics Inc
$0.8351-7.29%
SBIG Logo
SBIGSpringBig Holdings Inc
$0.0230-94.8%
  • The Trade: HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam acquired a total of 40,000 shares at an average price of $1.64. The insider spent $65.54 thousand to buy those shares.
  • What’s Happening: HCW Biologics posted an in-line loss for its first quarter
  • What HCW Biologics Does: HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases.
AUID Logo
AUIDAuthID Inc
$1.787.23%
Overview
HCWB Logo
HCWBHCW Biologics Inc
$0.8351-7.29%
SBIG Logo
SBIGSpringBig Holdings Inc
$0.0230-94.8%
Comments
Loading...